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AbstrACt
Introduction Physical activity is recommended for 
improving health among people with common chronic 
conditions such as obesity, diabetes, hypertension, 
osteoarthritis and low mood. One approach to promote 
physical activity is via primary care exercise referral 
schemes (ERS). However, there is limited support for 
the effectiveness of ERS for increasing long-term 
physical activity and additional interventions are needed 
to help patients overcome barriers to ERS uptake and 
adherence. This study aims to determine whether 
augmenting usual ERS with web-based behavioural 
support, based on the LifeGuide platform, will increase 
long-term physical activity for patients with chronic 
physical and mental health conditions, and is cost-
effective.
Methods and analysis A multicentre parallel two-group 
randomised controlled trial with 1:1 individual allocation 
to usual ERS alone (control) or usual ERS plus web-
based behavioural support (intervention) with parallel 
economic and mixed methods process evaluations. 
Participants are low active adults with obesity, diabetes, 
hypertension, osteoarthritis or a history of depression, 
referred to an ERS from primary care in the UK. The 
primary outcome measure is the number of minutes of 
moderate-to-vigorous physical activity (MVPA) in ≥10 
min bouts measured by accelerometer over 1 week at 12 
months. We plan to recruit 413 participants, with 88% 
power at a two-sided alpha of 5%, assuming 20% attrition, 
to demonstrate a between-group difference of 36–39 min 
of MVPA per week at 12 months. An improvement of this 
magnitude represents an important change in physical 
activity, particularly for inactive participants with chronic 
conditions.
Ethics and dissemination Approved by North West 
Preston NHS Research Ethics Committee (15/NW/0347). 
Dissemination will include publication of findings for 
the stated outcomes, parallel process evaluation and 
economic evaluation in peer-reviewed journals. Results 
will be disseminated to ERS services, primary healthcare 
providers and trial participants.
trial registration number ISRCTN15644451; Pre-results.
IntroduCtIon   
Physical inactivity was found to cost the 
National Health Service (NHS) £455 million 
in 2013–2014 according to data collected by 
Clinical Commissioning Groups in the UK.1 
strengths and limitations of this study
 ► This is the first study to determine whether adding 
web-based interventions to primary care exercise 
referral schemes increases objectively assessed 
physical activity more than usual exercise referral 
schemes, after 1 year.
 ► The study includes inactive adults with one or more 
common chronic conditions.
 ► No physical health measures (except self-reported 
weight) were assessed in the study.
 ► It is expected that participants will have multiple 
chronic conditions, meaning the study may not be 
able to determine intervention effects on physical 
activity for each condition.
 ► Participants in the intervention arm will be invited 
to take part in in-depth qualitative interviews which 
may act as a cointervention.
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Evidence-based guidelines recommend both aerobic 
and strength training for improving health markers and 
quality of life among those with common chronic meta-
bolic conditions2–5 and musculoskeletal conditions,6 and 
mostly aerobic exercise for preventing and reducing 
depression.7 Public health guidelines of 150 min of 
moderate-to-vigorous physical activity (MVPA) per week 
are widely accepted but even small increases in physical 
activity and reduced sedentary time among the least 
active are likely to accrue health benefits.8 9 
Patients with obesity, hypertension, type 2 diabetes, 
osteoarthritis and depression are less physically active 
than the general population,2 and need greater support 
to overcome real and perceived barriers to increase phys-
ical activity. Increases in physical activity among the least 
active have the potential to provide the largest impact on 
health but any benefits dissipate without maintained levels 
of activity.10 A variety of initiatives have been explored to 
promote physical activity within primary care, including 
referring patients to ‘exercise on prescription’, that is, 
an exercise referral scheme (ERS). In the UK, ERS have 
been common for promoting physical activity, with an 
estimated 600 schemes involving up to 100 000 patients 
per year.11
Evidence from a meta-analysis of eight randomised 
trials involving 5190 participants eligible for ERS12 
indicated a small increase in the proportion of partic-
ipants who achieved 90–150 min of physical activity of 
at least moderate intensity per week, compared with 
no exercise control at 6–12 months follow-up among 
at-risk individuals. But uncertainty remains regarding 
the effects for patients with specific medical conditions 
since no study assessed long-term physical activity objec-
tively, and many of the eight studies reviewed had rela-
tively small sample sizes.
A systematic review13 reported an average ERS uptake 
(attendance at the first ERS session) that ranged from 
66% in observational studies to 81% in randomised 
controlled trials, and average levels of adherence from 
49% in observational studies to 43% in randomised 
controlled trials. Predictors of uptake and adherence 
have rarely been explored but it has been reported that 
while women were more likely to begin an ERS, they were 
less likely to adhere to it than men; also, older people 
were more likely to begin and adhere to an ERS.13 ERS 
may help patients become familiar with concepts such as 
exercise type, intensity, frequency and duration of exer-
cise, matched to their medical condition, and target key 
processes of behaviour change. However, the following 
features of an ERS may reduce uptake and adherence: 
inconvenience, cost, limited sustainable physical activity 
support (eg, for 10 weeks) and low appeal for structured 
exercise and/or the medical model, that is, ‘exercise on 
prescription’, which may do little to provide autonomous 
support nor empower patients to develop self-deter-
mined behaviour to manage chronic medical condi-
tions.11 14 It therefore appears that additional support 
may be needed which is accessible, low cost, can be 
tailored to support a wide range of individual needs and 
empowers patients to develop and use self-regulatory 
skills (eg, self-monitoring, goal setting) to self-manage 
their chronic conditions. A wide variety of online and 
mobile technologies have been developed and used to 
support changes in and maintenance of physical activity.
There is considerable evidence on the effects of tech-
nology-based interventions for promotion of physical 
activity.15 16 These include studies with a wide range 
of interventions (from quite simple self-monitoring to 
interventions with complex multiple behaviour change 
components), targeted at different clinical groups 
with different baseline levels of physical activity, with 
various physical activity outcomes reported (very few 
using objective measures), and with mostly short-term 
follow-ups. Also, some comparisons are between inter-
vention versus no intervention and others versus human 
contact, although none reports on the effects of adding 
web-based support to ERS. The impact for web-based 
and technology interventions on increasing phys-
ical activity is small to moderate (an effect size ≤0.4). 
However, there is evidence that more rigorous studies, 
interventions with more behaviour change components 
and ones targeted at less active populations are more 
effective.15 16 A systematic review17 has highlighted 
the importance of maximising sustained engagement 
in web-based interventions for enhancing change in 
the target behaviour. A recent study18 confirmed that 
self-monitoring of physical activity and tailored feed-
back were important to increase engagement, and peri-
odic communications helped to maintain participant 
engagement.
The LifeGuide platform (www. LifeGuideonline. org/) 
has been extensively used to develop and evaluate 
acceptability and impact of online behaviour change 
and self-management interventions with a variety of 
clinical groups, including in primary care.19–21 For 
example, adding online LifeGuide support to face-
to-face support showed a greater lasting reduction in 
obesity than face-to-face dietetic advice alone.22 The 
LifeGuide platform provides a researcher-led tool to 
develop interventions drawn from theory and evidence 
of effective techniques23 24 and provides the opportu-
nity to understand engagement and utility of different 
behaviour change components.
Following iterative development work and user group 
testing and involvement, drawing on some online modules 
used in other LifeGuide interventions,19 we developed 
a bespoke intervention, called ‘e-coachER’ to support 
patients with chronic physical and mental health condi-
tions who have been referred from primary care to an 
ERS to receive face-to-face support. Should the approach 
prove to be effective, there is considerable potential for 
the intervention to be scaled up for patients with obesity, 
hypertension, type 2 diabetes, osteoarthritis and risk of 
depression at probable low cost25 26 and also extend it for 
patients with other chronic medical conditions (eg, low 
back pain, heart disease, cancer).
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AIM And objECtIvEs
The overarching aim is to determine if e-coachER online 
support combined with usual ERS provides an effective 
and cost-effective approach to supporting increases in 
physical activity in people referred to ERS with a range of 
chronic conditions.
The specific objectives are as follows:
 ► To determine whether in the intervention arm 
compared with the control arm, there is an increase 
in the total weekly minutes of MVPA at 12 months 
postrandomisation.
 ► To determine whether in the intervention arm 
compared with the control arm there is an increase in 
the proportion of participants who:
 – take up the opportunity to attend an initial consul-
tation with an exercise practitioner;
 – maintain objectively assessed physical activity from 
4 to 12 months postrandomisation;
 – maintain self-reported physical activity from 4 to 12 
months postrandomisation;
 – have improved health-related quality of life at 4 
and 12 months postrandomisation.
 ► To quantify the additional costs of delivering the inter-
vention and determine the differences in health utili-
sation and costs between the intervention and control 
arms at 12 months postrandomisation.
 ► To assess the cost-effectiveness of the intervention 
compared with control at 12 months postrandomisa-
tion (incremental cost per quality-adjusted life-year 
(QALY)) and over the lifetime perspective (incre-
mental cost per QALY).
 ► To quantitatively and qualitatively explore whether the 
impact of the intervention is moderated by medical 
condition, age, gender and socioeconomic status, IT 
literacy or ERS characteristics.
 ► To quantitatively and qualitatively explore the mech-
anisms through which the intervention may impact 
on the outcomes, through rigorous mixed methods 
process evaluation and mediation analyses (if 
appropriate).
MEthods And AnAlysIs
This protocol is reported in accordance with the Stan-
dard Protocol Items: Recommendations for Interven-
tional Trials guidance27 (http://www. spirit- statement. 
org/ spirit- statement/) for protocols of clinical trials 
and TIDieR guidelines28 (http://www. equator- network. 
org/ reporting- guidelines/ tidier/) for intervention 
description.
study design and setting
This is a multicentre parallel two-group randomised 
controlled trial with participant allocation to usual ERS 
alone (control) or usual ERS plus web-based behavioural 
support (intervention) with parallel economic and 
mixed methods process evaluations. The trial design is 
summarised in figure 1.
Recruitment to the trial will take place over a 21-month 
period (July 2015 to March 2017) in three areas in the 
UK, that is, Greater Glasgow, West Midlands and South 
West England (including Plymouth, Cornwall and Mid 
Devon). Only the latter includes some participants in 
more rural locations.
study population
The study population will include patients registered with 
a general practitioner (GP) surgery and who have been or 
are about to be referred to a local ERS for a programme 
of support to increase physical activity. Participants will be 
aged 16–74 years and have one of more of the following: 
obesity (body mass index (BMI), 30–40), a diagnosis of 
hypertension, prediabetes, type 2 diabetes, lower limb 
osteoarthritis or having a history of treatment for depres-
sion. Participants must also be categorised as ‘inactive’ or 
‘moderately inactive’ based on the GP Physical Activity 
Questionnaire,29 be contactable via email, and have some 
experience of using the internet. Patients are excluded if 
they meet any of the following criteria: have an unstable, 
severe and enduring mental health problem or are being 
treated for an alcohol or drug addiction that may limit 
their involvement with the study, do not meet the eligi-
bility criteria for their local ERS or are unable to use 
written materials in English unless a designated family 
member or friend can act as translator.
study procedures
Patient identification, approach and consent
Patients will be identified as potentially eligible for the 
trial (i) by healthcare professionals in primary care at 
the point of being actively referred to an ERS or having 
been opportunistically found to be eligible for an ERS 
at a consultation with the primary care practitioner, (ii) 
via a search of patient databases at the participating GP 
practices (conducted by the local Primary Care Research 
Network team), (iii) via patient self-referral to the GP 
arising from community-based publicity for the trial, (iv) 
by the ERS programme administrator on receipt of an 
ERS referral form from a GP practice or (v) by exercise 
advisors at the ERS service at enrolment on the ERS (with 
the patient’s consent, the exercise advisor will provide the 
local researcher with the patient’s contact details for the 
purposes of the trial).
Potentially eligible patients will be approached by 
the primary care practitioner or the local researcher, 
depending on how the patient was identified, or patients 
may self-refer to the local researcher in response to 
publicity campaigns. These various means of identifica-
tion and approach are designed to accommodate the vari-
ation in usual care referral pathways to ERS across the 
participating sites and individual GP practices.
Amenable patients will be offered a study-specific 
Participant Information Sheet, either by post, via 
email or by hand (the route used will largely depend 
on the preference of the participating GP practice 
or ERS service). Interested patients will be asked to 
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communicate their expression of interest to the local 
researcher via a prepaid reply slip, by telephone or by 
email. On receipt of an expression of interest, the local 
researcher will contact the potential participant by tele-
phone to discuss the trial, confirm eligibility and take 
informed consent.
Figure 1 Trial design/participant pathway.
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baseline assessment
Consented participants will attend a baseline assess-
ment with the local researcher. This assessment will be 
conducted over the telephone, or in person at the GP 
practice or at the centre delivering the ERS or another 
convenient community location. Demographic data 
will be collected. The participant will be issued with a 
wrist-worn waterproof accelerometer (GENEActiv Orig-
inal accelerometer http://www. geneactiv. org/) to wear 
constantly for one whole week (day and night), and a 
self-report questionnaire booklet to complete at the 
beginning of the week-long period. The accelerometer 
will be worn on the wrist of the non-dominant hand (ie, 
the hand not favoured for writing). After 1 week’s wear, 
participants will post the accelerometer and completed 
questionnaire to the Peninsula Clinical Trials Unit (CTU) 
in pre-addressed envelopes provided using a prepaid 
postal service. The measures collected at baseline and 
follow-up are shown in table 1.
randomisation
On receipt of the baseline accelerometer at the CTU after 
1 week’s wear, participants will be randomised. Randomi-
sation will be stratified by site with minimisation by the 
participant’s perceived reason for their referral to the ERS 
(ie, weight loss, diabetes control, reduce blood pressure, 
manage lower limb osteoarthritis symptoms, manage low 
mood/depression) and by self-reported IT literacy level 
on a visual analogue scale (ie, lower or higher confi-
dence). To maintain allocation concealment, the mini-
misation procedure will retain a stochastic element and 
will be conducted using a secure, password protected 
web-based system.
blinding
The ERS practitioners should be unaware of trial partic-
ipants’ treatment allocations. Blinding of participants is 
not possible, given the nature of the intervention. Given 
that the primary outcome is an objective measure of phys-
ical activity recorded by accelerometer, and the secondary 
outcomes will be assessed by participant self-completion 
questionnaire, the risk of assessor bias is likely to be negli-
gible in this study. However, to minimise any potential 
bias, the statistical analysis will be kept blinded and the 
code for group allocation not broken until the primary 
and secondary analyses have been completed.
Follow-up
At 4 weeks post-baseline, a short survey on initial uptake 
of the ERS will be administered via email.
At 4 and 12 months post-randomisation, participants 
will be sent an accelerometer and questionnaire booklet 
by post, along with a simple instruction sheet on how to 
wear the accelerometer, and a prepaid envelope to return 
the items to the CTU.
To maximise data completeness at follow-up assess-
ments, participants will be sent standard letters/emails 
from the CTU: (i) 7 days before delivery of the acceler-
ometer, (ii) 3 days into the 10-day recording window as a 
prompt for the participant to begin wearing the acceler-
ometer (if not already doing so) and (iii) should the accel-
erometer not have been received at the CTU, at 3 and 5 
Table 1 Schedule of baseline and follow-up measures
Measure Baseline Randomisation 4 weeks 4 months 12 months
Demographics X
Objectively measured physical activity (eg, minutes of 
MVPA in ≥10 min bouts, recorded by accelerometer)
X X X
Engagement with the ERS (uptake at 4 weeks, plus 
subsequent attendance at ERS, eg, number of sessions 
attended)
X                          X
Engagement with e-coachER (captured from the 
LifeGuide platform)
X X X
Self-reported:
 ► MVPA (7-day recall of physical activity)
 ► Health and social care resource use
 ► Quality of life measures: 5-level Euroqol-5D (EQ-5D-
5L), SF-12v2
 ► Hospital Anxiety and Depression Scale
X X X
Process evaluation outcomes (eg, self-reported 
confidence to be physically active; perceived frequency 
and availability of support; perceived autonomy over 
choices; involvement in self-monitoring and planning 
physical activity)
X X X
Qualitative interviews as part of the process evaluation 
focusing on participants’ experiences with the ERS and 
the intervention (optional for participants)
————————————————X————————
—————————
ERS, exercise referral scheme; MVPA, moderate- to- vigorous physical activity.
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weeks after issue as a reminder to post the accelerometer 
to the CTU. If the participant has not sent the accelerom-
eter to the CTU after 6 weeks, the local researcher will 
telephone the participant to remind them to return the 
device. Participants who return the accelerometer to the 
CTU will receive an online/high street store voucher for 
£20 as a token ‘thank you’, to maximise response rates.
trial treatment/trial arms
Intervention: web-based support plus ERS (e-coachER)
e-coachER is a web-based support package, which offers 
a range of interactive opportunities to enhance partic-
ipants’ motivation to take up the ERS and to maintain 
a more physically active lifestyle, whether or not they 
engage with their local ERS. A logic model for the inter-
vention is shown in figure 2.
e-coachER is primarily a self-delivered intervention and 
comprises the following components:
 ► A mailed ‘Welcome Pack’ that contains a user guide 
and the participant’s unique user log-in; a simple 
pedometer (step-counter) and a notepad to record 
daily physical activity (appended to a magnet with 
study-specific branding). Participants are encouraged 
to make use of the pedometer and the activity record 
sheets for self-monitoring and goal setting in conjunc-
tion with the e-coachER website.
 ► The e-coachER website (on the LifeGuide platform). 
At the core of e-coachER are seven ‘Steps to Health’ 
lasting approximately 5–10 min each, designed to: 
encourage participants to think about the benefits 
of physical activity (motivation); seek support from 
an ERS practitioner, friends/family and the internet 
(support/relatedness); set progressive goals; self-mon-
itor physical activity with a pedometer and upload step 
counts or minutes of MVPA (self-regulation, building 
confidence/autonomy); find ways to increase physical 
activity more sustainably in the context of day-to-day 
life and deal with setbacks (building confidence). 
The sequential content, objectives and how this was 
Figure 2 Logic model for e-coachER intervention. ERS, exercise referral scheme; MVPA, moderate- to- vigorous physical 
activity.
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implemented were mapped against a taxonomy for 
behaviour change techniques30 (table 2). Self-de-
termination theory underpins the intervention with 
core aims in every step and interaction with partici-
pants, aiming to build confidence, autonomy and 
relatedness.31
Participants are encouraged to use the e-coachER 
support package as an interactive tool by using preset 
or user-defined reminders to promote ongoing use of 
functions such as recording weekly physical activity 
(minutes of MVPA) and goal setting, and receive 
messages of encouragement. Prompts are sent to 
remind participants to review their goals. An absence 
of engagement (eg, failure to review a goal, or not 
signing into the website for 1, 2 and 4 weeks) triggers 
reminder emails to the participant.
The website content will be locked prior to starting 
recruitment, with the exception of webpages 
displaying links to reputable generic websites for 
further information about the chronic conditions of 
interest and lifestyle, links to other websites and apps 
for self-monitoring health behaviour and health as 
well as modifiable listings of local opportunities to 
engage in physical activity.
An avatar is used throughout the content to avoid 
having to represent a range of individual character-
istics such as age, gender and ethnicity. The avatar 
delivers brief narratives to normalise and support 
behaviour change and encourage use of the e-coachER 
support package.
 ► To maximise accessibility and usage, a local researcher 
will provide technical support if requested. If a partici-
pant does not register on the e-coachER website within 
the first few weeks, the local researcher will contact 
the participant to offer support to register. If a partici-
pant requires technical support to resolve operational 
issues with the website (eg, requires a password to be 
reissued), participants will be referred to a centralised 
technician within the LifeGuide team.
Intervention development, including piloting the 
Welcome Pack and developing an initial version of 
e-coachER, was built on wide ranging experiences from 
the development of other self-management interventions 
using the LifeGuide platform,32 and beta-testing over 
7 months with input from service users. Co-applicants 
and researchers then provided feedback on a time-trun-
cated version of the e-coachER website, and ERS patients 
provided feedback on a real-time version, for 5 months 
before the website was locked for the randomised 
controlled trial.
Usual care
There is currently no single model for ERS in the UK, but 
the predominant modes of delivery involve referral to a 
programme (eg, 10–12 weeks) of structured, supervised 
exercise at an exercise facility (eg, gym or leisure centre) 
or a counselling approach to support patients to engage 
in a variety of types of physical activity.11 ERS operate 
diversely to accommodate patient choice and local avail-
ability of facilities, the common goal being to reduce the 
risk of long-term metabolic, musculoskeletal and mental 
health conditions due to physical inactivity. The three 
participating sites were selected from different regions of 
the UK (different ERS providers) to provide diversity of 
approach; the schemes are described in table 3.
determination of sample size
In the absence of a published minimally important 
difference for MVPA, assuming a ‘small’ to ‘moderate’ 
standardised effect size of 0.35, we estimated that 413 
participants are required at 88% power and a two-sided 
alpha of 5% assuming 20% attrition, or 90% power at a 
two-sided alpha of 5% allowing for 16% attrition (using 
‘sampsi’ in STATA V.14). Given that the intervention is 
being delivered at the level of the individual participant, 
clustering has not been factored into the sample size 
calculation. Based on the baseline SD for MVPA total 
weekly minutes in ≥10 min bouts of 104–113,33 an effect 
size of 0.35 would correspond to a between-group differ-
ence of 36–39 min of MVPA per week.
Measures
Primary outcome measure
The primary outcome is the number of weekly minutes of 
MVPA, in ≥10 min bouts, measured objectively by GENE-
Activ Original accelerometer,34 over 1 week at 12 months 
post-randomisation compared with the control group. 
To be included participants need to provide activity 
recorded over 4 days, including a weekend day, for at least 
16 hours/day.
Additional measures
 ► Total weekly minutes of MVPA in ≥10 min bouts, 
measured objectively by accelerometer, over 1 week at 
4 months.
 ► Achievement of at least 150 min of MVPA, measured 
objectively by accelerometer, over 1 week at 4 and 12 
months.
 ► Achievement of at least 150 min of MVPA over 1 week 
using the self-reported 7-day Physical Activity Recall 
Questionnaire at 4 and 12 months.
 ► Self-reported weekly minutes of MVPA at 4 and 12 
months.
 ► Average daily hours of sedentary behaviour measured 
objectively by accelerometer over 1 week at 4 and 12 
months.
 ► Self-reported average daily hours of sleep over 1 week 
at 4 and 12 months.
 ► Self-reported health-related quality of life, assessed by 
the EQ-5D-5L35and SF-12v236 at 4 and 12 months.
 ► Self-reported symptoms of anxiety and depression, 
assessed by the Hospital Anxiety and Depression 
Scale37 at 4 and 12 months.
 ► Uptake of the ERS by participant self-report at 
approximately 4 weeks and at 4 months, and from ERS 
records.
 o
n
 5 D
ecem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022382 on 21 September 2018. Downloaded from 
8 Ingram W, et al. BMJ Open 2018;8:e022382. doi:10.1136/bmjopen-2018-022382
Open access 
Ta
b
le
 2
 
Th
e 
e-
co
ac
hE
R
 s
eq
ue
nt
ia
l p
ro
ce
ss
 a
nd
 o
b
je
ct
iv
es
 m
ap
p
ed
 a
ga
in
st
 b
eh
av
io
ur
 c
ha
ng
e 
te
ch
ni
q
ue
s,
 a
nd
 e
xp
la
na
tio
n 
of
 t
he
 im
p
le
m
en
ta
tio
n 
st
ra
te
gy
S
eq
ue
nt
ia
l p
ro
ce
ss
P
er
fo
rm
an
ce
 o
b
je
ct
iv
es
B
eh
av
io
ur
 c
ha
ng
e 
te
ch
ni
q
ue
s3
0
Im
p
le
m
en
ta
ti
o
n 
st
ra
te
g
y
W
el
co
m
e 
p
ac
k,
 p
ed
om
et
er
 
an
d
 In
tr
od
uc
tio
n 
to
 w
eb
-
b
as
ed
 s
up
p
or
t 
fo
r 
se
lf-
d
ire
ct
ed
 p
hy
si
ca
l a
ct
iv
ity
To
 in
tr
od
uc
e 
th
e 
us
er
 t
o 
th
e 
p
hi
lo
so
p
hy
 o
f t
he
 
w
eb
si
te
 t
o 
b
ec
om
e 
p
er
so
na
l c
oa
ch
.
B
ui
ld
 o
n 
p
er
so
na
l s
up
p
or
t 
p
ro
vi
d
ed
 b
y 
E
R
S
 
us
in
g 
w
eb
-b
as
ed
 p
la
tf
or
m
.
S
up
p
or
t 
th
os
e 
w
ho
 d
o 
no
t 
w
an
t 
to
/c
an
no
t 
en
ga
ge
 w
ith
 E
R
S
 p
er
so
nn
el
.
S
up
p
or
t 
ac
hi
ev
em
en
t 
of
 p
er
so
na
l g
oa
ls
 fo
r 
p
hy
si
ca
l a
ct
iv
ity
 t
o 
en
ha
nc
e 
he
al
th
.
10
. S
el
f-
m
on
ito
rin
g
E
xp
la
in
 p
hi
lo
so
p
hy
 o
f u
si
ng
 w
eb
si
te
 t
o 
b
ec
om
e 
ow
n 
p
er
so
na
l c
oa
ch
.
Li
nk
s 
p
ro
vi
d
ed
 t
o 
lo
ca
l s
er
vi
ce
s 
an
d
 o
th
er
 s
el
f-
he
lp
 r
es
ou
rc
es
 t
o 
hi
gh
lig
ht
 
p
at
ie
nt
 a
ut
on
om
y 
an
d
 c
ho
ic
e.
O
ffe
rs
 e
-c
oa
ch
E
R
 fa
ci
lit
at
or
 t
o 
he
lp
 w
ith
 u
si
ng
 t
ec
hn
ol
og
y.
 P
ro
vi
d
e 
lin
k 
to
 IT
 
su
p
p
or
t 
fr
om
 L
ife
G
ui
d
e 
te
am
.
S
te
p
 1
: t
hi
nk
in
g 
ab
ou
t 
th
e 
b
en
efi
ts
 o
f p
hy
si
ca
l a
ct
iv
ity
E
le
va
te
 im
p
or
ta
nc
e 
of
 p
hy
si
ca
l a
ct
iv
ity
.
82
. I
nf
or
m
at
io
n 
ab
ou
t 
he
al
th
 
co
ns
eq
ue
nc
es
83
. I
nf
or
m
at
io
n 
ab
ou
t 
em
ot
io
na
l 
co
ns
eq
ue
nc
es
Q
ui
z 
to
 e
ng
ag
e 
p
ar
tic
ip
an
ts
 u
si
ng
 p
os
iti
ve
 fr
am
in
g.
P
ro
vi
d
e 
ev
id
en
ce
 o
f m
ul
tip
le
 b
en
efi
ts
 o
f p
hy
si
ca
l a
ct
iv
ity
, e
sp
ec
ia
lly
 fo
r 
re
le
va
nt
 h
ea
lth
 c
on
d
iti
on
(s
).
E
lic
it 
an
d
 a
d
d
re
ss
 c
on
ce
rn
s 
ab
ou
t 
p
hy
si
ca
l a
ct
iv
ity
, d
es
cr
ib
in
g 
su
p
p
or
t 
gi
ve
n 
as
 p
ar
t 
of
 E
R
S
 a
nd
 b
y 
w
eb
si
te
.
S
te
p
 2
: s
up
p
or
t 
to
 g
et
 
ac
tiv
e
To
 e
nc
ou
ra
ge
 u
se
r 
to
 a
cc
es
s 
an
d
 c
re
at
e 
so
ci
al
 
su
p
p
or
t 
ne
tw
or
ks
.
To
 e
nc
ou
ra
ge
 u
se
r 
to
 t
ak
e 
ad
va
nt
ag
e 
of
 E
R
S
 
an
d
 fa
ce
-t
o-
fa
ce
 s
up
p
or
t 
of
fe
re
d
.
1.
 S
oc
ia
l s
up
p
or
t 
(p
ra
ct
ic
al
)
2.
 S
oc
ia
l s
up
p
or
t 
(e
m
ot
io
na
l)
3.
 S
oc
ia
l s
up
p
or
t 
(u
ns
p
ec
ifi
ed
)
E
xp
la
in
 h
ow
 t
o 
m
ak
e 
th
e 
m
os
t 
ou
t 
of
 t
he
 E
R
S
 s
up
p
or
t 
to
 le
ar
n 
ho
w
 t
o 
b
ec
om
e 
ow
n 
p
er
so
na
l t
ra
in
er
 in
 fu
tu
re
.
E
xp
la
in
 h
ow
 u
se
r 
ca
n 
cr
ea
te
 a
 p
er
so
na
l ‘
p
hy
si
ca
l a
ct
iv
ity
 c
ha
lle
ng
e’
 a
nd
 
sh
ar
e 
it 
w
ith
 fa
m
ily
, f
rie
nd
s,
 p
ee
rs
 a
nd
 e
xe
rc
is
e 
an
d
 h
ea
lth
 p
ro
fe
ss
io
na
ls
. T
he
 
p
at
ie
nt
 m
ay
 b
e 
en
co
ur
ag
ed
 t
o 
te
ll 
ot
he
rs
 a
b
ou
t 
ho
w
 e
-c
oa
ch
E
R
 h
as
 b
ee
n 
us
ed
 t
o 
su
p
p
or
t 
b
eh
av
io
ur
 c
ha
ng
e.
S
ug
ge
st
 w
ay
s 
of
 in
vo
lv
in
g 
fa
m
ily
 o
r 
fr
ie
nd
s 
in
 lo
ng
-t
er
m
 s
up
p
or
t 
fo
r 
co
nt
in
ue
d
 p
hy
si
ca
l a
ct
iv
ity
.
Li
nk
 t
o 
on
lin
e 
so
ur
ce
s 
of
 lo
ca
l s
up
p
or
t 
(e
g,
 lo
ca
l w
al
ki
ng
 o
r 
jo
gg
in
g 
gr
ou
p
, o
r 
B
rit
is
h 
Tr
us
t 
fo
r 
C
on
se
rv
at
io
n 
Vo
lu
nt
ee
rs
).
H
ow
 t
o 
us
e 
w
eb
si
te
 t
o 
se
nd
 p
er
so
na
lis
ed
 e
m
ai
l/t
ex
t 
re
m
in
d
er
s,
 m
ot
iv
at
io
na
l 
m
es
sa
ge
s 
to
 s
el
f.
D
ra
w
 o
n 
p
os
iti
ve
 n
or
m
at
iv
e 
b
el
ie
fs
; i
d
en
tif
y 
b
en
efi
ts
 o
f s
oc
ia
l i
nt
er
ac
tio
n 
(c
om
p
an
io
ns
hi
p
). 
S
ha
rin
g 
p
er
so
na
l p
hy
si
ca
l a
ct
iv
ity
 c
ha
lle
ng
e 
w
ith
 o
th
er
s,
 
in
vo
lv
e 
fr
ie
nd
s 
an
d
 fa
m
ily
, o
nl
in
e 
lo
ca
l s
up
p
or
t 
lin
ks
.
Id
en
tif
y 
b
en
efi
ts
 o
f i
nf
or
m
at
io
na
l s
up
p
or
t 
(fr
om
 E
R
S
) i
n 
ad
d
iti
on
 t
o 
em
ot
io
na
l 
su
p
p
or
t 
fr
om
 fa
m
ily
 a
nd
 fr
ie
nd
s.
S
te
p
 3
: c
ou
nt
in
g 
yo
ur
 s
te
p
s
To
 e
nc
ou
ra
ge
 a
nd
 s
up
p
or
t 
th
e 
us
er
 t
o 
m
on
ito
r 
st
ep
 c
ou
nt
s 
us
in
g 
a 
p
ed
om
et
er
 o
ve
r 
a 
w
ee
k.
E
m
p
ha
si
se
 p
er
so
na
l e
xp
er
im
en
ta
tio
n.
10
. S
el
f-
m
on
ito
rin
g 
of
 b
eh
av
io
ur
P
ro
vi
d
e 
gu
id
an
ce
 o
n 
ho
w
 t
o 
co
un
t 
st
ep
s/
us
e 
p
ed
om
et
er
.
P
ro
vi
d
e 
gu
id
an
ce
 o
n 
ho
w
 s
te
p
s 
ca
n 
b
e 
im
p
le
m
en
te
d
 in
to
 li
fe
st
yl
e.
E
nc
ou
ra
ge
 s
el
f-
m
on
ito
rin
g 
us
in
g 
d
ia
ry
.
S
te
p
 4
: m
ak
in
g 
yo
ur
 s
te
p
 
p
la
ns
To
 s
et
 e
xp
lic
it 
st
ep
 c
ou
nt
 g
oa
ls
 fo
r 
th
e 
fo
llo
w
in
g 
w
ee
k.
66
. G
oa
l s
et
tin
g 
(b
eh
av
io
ur
)
G
iv
e 
ra
tio
na
le
 a
nd
 e
vi
d
en
ce
 fo
r 
go
al
-s
et
tin
g 
fo
r 
gr
ad
ed
 in
cr
ea
se
 in
 p
hy
si
ca
l 
ac
tiv
ity
.
U
se
r 
se
ts
 s
p
ec
ifi
c,
 a
ch
ie
va
b
le
 g
oa
ls
 fo
r 
ne
xt
 w
ee
k 
(e
g,
 s
es
si
on
s 
co
m
p
le
te
d
, 
st
ep
 c
ou
nt
 u
si
ng
 t
he
 s
up
p
lie
d
 p
ed
om
et
er
s)
.
Li
nk
s 
p
ro
vi
d
ed
 t
o 
lo
ca
l s
er
vi
ce
s 
an
d
 o
th
er
 r
es
ou
rc
es
.
S
te
p
 5
: m
ak
in
g 
yo
ur
 a
ct
iv
ity
 
p
la
ns
To
 e
nc
ou
ra
ge
 a
nd
 s
up
p
or
t 
th
e 
us
er
 t
o 
id
en
tif
y 
b
eh
av
io
ur
al
 g
oa
ls
 (t
yp
es
 o
f a
ct
iv
iti
es
).
68
. A
ct
io
n 
p
la
nn
in
g
U
se
r 
se
le
ct
s 
w
al
ki
ng
 o
r 
‘o
th
er
 p
hy
si
ca
l a
ct
iv
iti
es
’ (
w
hi
ch
 in
cl
ud
es
 o
p
tio
ns
 fo
r 
fa
ci
lit
y-
b
as
ed
 a
ct
iv
ity
 w
ith
 p
ra
ct
iti
on
er
 s
up
p
or
t 
w
ith
in
 E
R
S
).
P
re
se
nt
 o
p
tio
ns
 fo
r 
fa
ci
lit
y 
an
d
 li
fe
st
yl
e-
b
as
ed
 a
ct
iv
ity
.
S
et
s 
sp
ec
ifi
c,
 a
ch
ie
va
b
le
 g
oa
ls
 fo
r 
ne
xt
 w
ee
k 
w
ith
 a
 p
ar
tic
ul
ar
 fo
cu
s 
on
 
av
oi
d
in
g 
d
ay
s 
w
ith
 le
ss
 a
ct
iv
ity
 b
y 
p
la
nn
in
g 
w
al
ki
ng
 o
r 
ot
he
r 
ac
tiv
iti
es
.
K
ee
p
in
g 
a 
p
hy
si
ca
l a
ct
iv
ity
 d
ia
ry
.
C
on
tin
ue
d
 o
n
 5 D
ecem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022382 on 21 September 2018. Downloaded from 
9Ingram W, et al. BMJ Open 2018;8:e022382. doi:10.1136/bmjopen-2018-022382
Open access
S
eq
ue
nt
ia
l p
ro
ce
ss
P
er
fo
rm
an
ce
 o
b
je
ct
iv
es
B
eh
av
io
ur
 c
ha
ng
e 
te
ch
ni
q
ue
s3
0
Im
p
le
m
en
ta
ti
o
n 
st
ra
te
g
y
W
ee
kl
y 
go
al
 a
nd
 p
hy
si
ca
l 
ac
tiv
ity
 r
ev
ie
w
To
 p
ro
m
ot
e 
ad
he
re
nc
e 
an
d
 g
ra
d
ed
 in
cr
ea
se
 in
 
p
hy
si
ca
l a
ct
iv
ity
 b
y 
p
ro
vi
d
in
g 
ta
ilo
re
d
 fe
ed
b
ac
k 
an
d
 a
d
vi
ce
 b
as
ed
 o
n 
se
lf-
re
p
or
te
d
 g
oa
l 
p
ro
gr
es
s.
66
. G
oa
l s
et
tin
g 
b
eh
av
io
ur
68
. A
ct
io
n 
p
la
nn
in
g
69
. R
ev
ie
w
 b
eh
av
io
ur
 g
oa
ls
U
se
r 
re
co
rd
s 
ex
te
nt
 t
o 
w
hi
ch
 g
oa
ls
 a
ch
ie
ve
d
 in
 p
re
vi
ou
s 
w
ee
k,
 g
et
s 
p
ro
gr
es
s 
gr
ap
h 
an
d
 p
er
so
na
lis
ed
 fe
ed
b
ac
k.
P
ra
is
e 
fo
r 
an
y 
go
al
 a
ch
ie
ve
m
en
t,
 e
nc
ou
ra
ge
m
en
t 
to
 s
et
 a
 m
or
e 
ch
al
le
ng
in
g 
go
al
 if
 n
ot
 y
et
 m
ee
tin
g 
ta
rg
et
 p
hy
si
ca
l a
ct
iv
ity
 c
rit
er
ia
.
E
nc
ou
ra
ge
m
en
t 
w
he
re
 g
oa
ls
 n
ot
 a
tt
ai
ne
d
, w
ith
 li
nk
s 
to
 w
eb
p
ag
es
 t
o 
as
si
st
 
w
ith
 in
cr
ea
si
ng
 m
ot
iv
at
io
n 
or
 c
on
fid
en
ce
, s
el
ec
tin
g 
d
iff
er
en
t 
ac
tiv
iti
es
 o
r 
go
al
s,
 m
ak
in
g 
b
et
te
r 
p
la
ns
, a
cc
es
si
ng
 s
up
p
or
t,
 o
ve
rc
om
in
g 
se
tb
ac
ks
 (w
ith
 
lin
ks
 t
o 
re
le
va
nt
 s
es
si
on
s 
b
el
ow
).
E
ac
h 
se
ss
io
n 
co
m
p
le
te
d
 e
nd
s 
w
ith
 n
ew
 li
nk
s 
to
 r
ep
ut
ab
le
 in
fo
rm
at
io
n 
an
d
 
re
so
ur
ce
s 
(e
g,
 N
H
S
 c
ho
ic
es
, c
on
d
iti
on
-s
p
ec
ifi
c 
p
hy
si
ca
l a
ct
iv
ity
 a
d
vi
ce
 
w
eb
si
te
s)
.
H
el
p
 u
se
r 
p
la
n 
gr
ad
ua
l i
nc
re
as
es
 in
 p
hy
si
ca
l a
ct
iv
ity
.
S
te
p
 6
: fi
nd
in
g 
w
ay
s 
to
 
ac
hi
ev
e 
yo
ur
 p
la
ns
To
 h
el
p
 t
he
 u
se
r 
ha
rn
es
s 
th
ei
r 
en
vi
ro
nm
en
t 
to
 
p
ro
vi
d
e 
su
p
p
or
t 
fo
r 
p
hy
si
ca
l a
ct
iv
ity
.
Id
en
tif
yi
ng
 p
er
so
na
l m
ot
iv
at
io
ns
, b
ui
ld
in
g 
co
nfi
d
en
ce
.
30
. R
es
tr
uc
tu
rin
g 
th
e 
p
hy
si
ca
l 
en
vi
ro
nm
en
t
31
. R
es
tr
uc
tu
rin
g 
th
e 
so
ci
al
 
en
vi
ro
nm
en
t
32
. A
vo
id
an
ce
/r
ed
uc
in
g 
ex
p
os
ur
e 
to
 
cu
es
 fo
r 
b
eh
av
io
ur
M
ak
e 
p
la
n 
to
 u
se
 e
nv
iro
nm
en
t 
to
 a
ut
om
at
ic
al
ly
 s
up
p
or
t 
p
hy
si
ca
l a
ct
iv
ity
 (e
g,
 
fit
ne
ss
 e
q
ui
p
m
en
t 
in
 li
vi
ng
 r
oo
m
, r
ou
te
 t
o 
w
or
k/
sh
op
s 
th
at
 in
vo
lv
es
 m
or
e 
p
hy
si
ca
l a
ct
iv
ity
, c
om
m
itt
in
g 
se
lf 
to
 s
p
ec
ifi
c 
ro
ut
in
e)
.
A
d
vi
se
 u
se
r 
on
 h
ow
 t
o 
us
e 
w
eb
si
te
 t
o 
se
nd
 p
er
so
na
lis
ed
 e
m
ai
l/t
ex
t 
re
m
in
d
er
s,
 m
ot
iv
at
io
na
l m
es
sa
ge
s.
O
ve
rc
om
in
g 
b
ar
rie
rs
 in
 w
or
k,
 le
is
ur
e,
 h
om
e 
an
d
 t
ra
ve
l. 
B
ui
ld
in
g 
se
lf-
ef
fic
ac
y.
U
si
ng
 s
m
ar
t 
p
ho
ne
 a
p
p
s 
fo
r 
m
ob
ile
 s
up
p
or
t 
(e
g,
 P
ow
er
Tr
ac
ke
r 
(c
), 
M
yF
itn
es
sP
al
 (c
)).
In
vi
te
 u
se
r 
to
 id
en
tif
y 
p
er
so
na
l m
ot
iv
at
io
ns
 fo
r 
b
ec
om
in
g 
m
or
e 
ac
tiv
e.
M
ot
iv
at
io
na
l m
es
sa
ge
s 
(te
xt
 
an
d
/o
r 
em
ai
ls
)
To
 p
ro
vi
d
e 
re
m
in
d
er
s 
of
 u
se
r'
s 
p
er
so
na
l 
re
as
on
s 
(n
ot
 n
ec
es
sa
ril
y 
he
al
th
 r
ea
so
ns
) f
or
 
b
ec
om
in
g 
m
or
e 
ac
tiv
e.
15
. P
ro
m
p
ts
/c
ue
s
In
vi
te
 u
se
r 
to
 w
rit
e 
m
ot
iv
at
io
na
l m
es
sa
ge
 t
o 
b
e 
se
nt
 w
ee
kl
y 
or
 m
on
th
ly
 
d
et
ai
lin
g 
th
ei
r 
ow
n 
m
ot
iv
at
io
ns
 fo
r 
b
ec
om
in
g 
m
or
e 
ac
tiv
e.
S
te
p
 7
: d
ea
lin
g 
w
ith
 
se
tb
ac
ks
To
 p
ro
vi
d
e 
st
ra
te
gi
es
 fo
r 
ov
er
co
m
in
g 
re
la
p
se
 in
 
le
ve
ls
 o
f p
hy
si
ca
l a
ct
iv
ity
.
5.
 R
ed
uc
e 
ne
ga
tiv
e 
em
ot
io
ns
Id
en
tif
y 
p
os
si
b
le
 c
au
se
s 
of
 r
el
ap
se
 (e
g,
 il
ln
es
s,
 h
ol
id
ay
s,
 c
ha
ng
e 
in
 w
or
k 
ho
ur
s,
 n
ew
 c
ar
in
g 
re
sp
on
si
b
ili
tie
s)
 a
nd
 p
la
n 
w
ay
s 
to
 o
ve
rc
om
e 
b
ar
rie
rs
.
C
ha
lle
ng
in
g 
ca
ta
st
ro
p
hi
c 
ne
ga
tiv
e 
th
ou
gh
ts
 a
b
ou
t 
la
p
se
s 
fr
om
 in
te
nd
ed
 
p
hy
si
ca
l a
ct
iv
ity
.
H
ow
 t
o 
le
ar
n 
fr
om
 a
 la
p
se
 a
nd
 p
la
n 
to
 a
vo
id
 o
r 
ov
er
co
m
e 
in
 fu
tu
re
.
P
ro
vi
d
e 
sa
lie
nt
 r
ol
e 
m
od
el
s 
of
 p
eo
p
le
 o
ve
rc
om
in
g 
b
ar
rie
rs
 t
o 
su
cc
es
sf
ul
ly
 
en
ga
ge
 w
ith
 p
hy
si
ca
l a
ct
iv
ity
.
E
R
S
, e
xe
rc
is
e 
re
fe
rr
al
 s
ch
em
e.
 
Ta
b
le
 2
 
C
on
tin
ue
d
 
 o
n
 5 D
ecem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022382 on 21 September 2018. Downloaded from 
10 Ingram W, et al. BMJ Open 2018;8:e022382. doi:10.1136/bmjopen-2018-022382
Open access 
Ta
b
le
 3
 
C
ha
ra
ct
er
is
tic
s 
of
 t
he
 lo
ca
l E
R
S
 in
vo
lv
ed
 in
 t
he
 s
tu
d
y
S
o
ut
h 
W
es
t 
E
ng
la
nd
 (p
re
d
o
m
in
an
tl
y 
P
ly
m
o
ut
h)
W
es
t 
M
id
la
nd
s 
(B
ir
m
in
g
ha
m
)
G
re
at
er
 G
la
sg
o
w
 a
nd
 C
ly
d
e 
(G
G
C
) H
ea
lt
h 
B
o
ar
d
 
A
re
a
P
op
ul
at
io
n 
of
 c
ity
/
lo
ca
lit
y 
an
d
 g
en
er
al
 
ch
ar
ac
te
ris
tic
s
26
4 
00
0
93
%
 W
hi
te
 B
rit
is
h.
A
ve
ra
ge
 a
ge
 is
 3
9 
ye
ar
s.
P
ly
m
ou
th
 h
as
 h
ig
he
r 
th
an
 a
ve
ra
ge
 le
ve
ls
 o
f p
ov
er
ty
 
an
d
 d
ep
riv
at
io
n 
(2
6.
2%
 o
f p
op
ul
at
io
n 
am
on
g 
th
e 
p
oo
re
st
 2
0.
4%
 n
at
io
na
lly
).
Li
fe
 e
xp
ec
ta
nc
y,
 a
t 
78
.3
 y
ea
rs
 fo
r 
m
en
 a
nd
 8
2.
1 
fo
r 
w
om
en
, i
s 
th
e 
lo
w
es
t 
of
 a
ny
 r
eg
io
n 
in
 t
he
 S
ou
th
 
W
es
t 
of
 E
ng
la
nd
.
1 
24
4 
43
8
W
hi
te
 B
rit
is
h 
(5
3.
1%
), 
P
ak
is
ta
ni
 
(1
3.
5%
) a
nd
 In
d
ia
n 
(6
%
). 
B
irm
in
gh
am
 
is
 r
an
ke
d
 t
he
 s
ix
th
 m
os
t 
d
ep
riv
ed
 lo
ca
l 
au
th
or
ity
 in
 t
he
 U
K
.
A
p
p
ro
xi
m
at
el
y 
40
%
 o
f t
he
 p
op
ul
at
io
n 
liv
es
 in
 h
ig
hl
y 
d
ep
riv
ed
 a
re
as
.
Th
e 
av
er
ag
e 
lif
e 
ex
p
ec
ta
nc
y 
in
 
B
irm
in
gh
am
 is
 7
7.
1 
ye
ar
s 
fo
r 
m
al
es
 a
nd
 
81
.9
 y
ea
rs
 fo
r 
fe
m
al
es
.
1 
16
1  
37
0
G
G
C
 is
 t
he
 la
rg
es
t 
he
al
th
 b
oa
rd
 in
 t
he
 U
K
, c
om
p
ris
in
g 
si
x 
lo
ca
l a
ut
ho
rit
y 
ar
ea
s:
 9
2.
5%
 w
hi
te
, 5
.3
%
 A
si
an
, 
A
si
an
 S
co
tt
is
h 
or
 A
si
an
 B
rit
is
h,
 1
.2
%
 A
fr
ic
an
, 0
.2
%
 
C
ar
ib
b
ea
n 
or
 b
la
ck
, 0
.4
%
 m
ix
ed
, 0
.4
%
 o
th
er
.
Th
er
e 
is
 la
rg
e 
va
ria
tio
n 
in
 d
ep
riv
at
io
n 
ac
ro
ss
 G
G
C
, b
ut
 
as
 a
 w
ho
le
, i
t 
ex
p
er
ie
nc
es
 h
ig
he
r 
th
an
 a
ve
ra
ge
 le
ve
ls
 
of
 d
ep
riv
at
io
n 
an
d
 p
ov
er
ty
 (3
4.
4%
 p
op
ul
at
io
n 
am
on
g 
th
e 
p
oo
re
st
 1
2.
4%
 n
at
io
na
l a
ve
ra
ge
).
Li
fe
 e
xp
ec
ta
nc
y 
at
 7
4.
9 
ye
ar
s 
fo
r 
m
al
es
 a
nd
 8
0.
0 
ye
ar
s 
fo
r 
fe
m
al
es
, i
s 
th
e 
lo
w
es
t 
in
 S
co
tla
nd
.
N
um
b
er
 o
f c
en
tr
es
/
fa
ci
lit
ie
s 
w
he
re
 
re
fe
rr
al
s 
ar
e 
m
ad
e 
to
 
in
 t
he
 E
R
S
O
ne
 m
ai
n 
E
R
S
 r
un
 b
y 
E
ve
ry
on
e 
A
ct
iv
e 
in
 P
ly
m
ou
th
 
an
d
 t
w
o 
sm
al
le
r 
on
es
 in
 r
ur
al
 lo
ca
tio
ns
.
R
ef
er
ra
ls
 fo
r 
E
R
S
 c
am
e 
fr
om
 3
1 
lo
ca
l G
P
 p
ra
ct
ic
es
.
O
ne
 m
ai
n 
E
R
S
, B
e 
A
ct
iv
e 
P
lu
s 
ru
n 
b
y 
B
irm
in
gh
am
 C
ity
 C
ou
nc
il 
W
el
lb
ei
ng
 
S
er
vi
ce
.
R
ef
er
ra
ls
 fo
r 
E
R
S
 c
am
e 
fr
om
 2
86
 lo
ca
l 
G
P
 p
ra
ct
ic
es
.
O
ne
 m
ai
n 
E
R
S
 (L
iv
e 
A
ct
iv
e)
 d
el
iv
er
ed
 b
y 
si
x 
lo
ca
l 
le
is
ur
e 
tr
us
ts
 in
 s
ix
 lo
ca
l a
ut
ho
rit
y 
ar
ea
s 
of
 G
G
C
 
(G
la
sg
ow
, E
as
t 
R
en
fr
ew
sh
ire
, R
en
fr
ew
sh
ire
, E
as
t 
D
un
b
ar
to
ns
hi
re
, W
es
t 
D
un
b
ar
to
ns
hi
re
 a
nd
 In
ve
rc
ly
d
e)
.
R
ef
er
ra
ls
 a
re
 p
os
si
b
le
 fr
om
 a
ny
 h
ea
lth
 p
ro
fe
ss
io
na
l i
n 
p
rim
ar
y 
an
d
 s
ec
on
d
ar
y 
ca
re
.
W
ee
ks
, s
es
si
on
s 
an
d
 
ge
ne
ra
l d
et
ai
ls
 a
b
ou
t 
E
R
S
S
ch
em
es
 v
ar
y 
fr
om
 6
 t
o 
12
 w
ee
ks
, a
tt
en
d
ee
s 
sh
ou
ld
 c
om
m
it 
to
 a
 m
in
im
um
 o
f t
w
o 
se
ss
io
ns
/w
ee
k 
in
 t
he
 g
ym
 w
ith
 d
r o
p
-i
n 
sw
im
m
in
g,
 a
q
ua
fit
 a
nd
 
ge
nt
le
 e
xe
rc
is
e 
gr
ou
p
 s
es
si
on
s 
av
ai
la
b
le
 t
o 
al
l.
A
ll 
E
R
S
 r
ef
er
ra
ls
 a
re
 r
is
k 
as
se
ss
ed
 a
s 
lo
w
 o
r 
m
ed
iu
m
 r
is
k.
 T
ho
se
 c
la
ss
ed
 a
t 
m
ed
iu
m
 r
is
k 
m
ay
 
on
ly
 a
tt
en
d
 a
 s
up
er
vi
se
d
 s
es
si
on
. A
d
d
iti
on
al
ly
, a
 
‘w
al
ki
ng
 fo
r 
he
al
th
’ s
ch
em
e 
is
 h
ig
hl
ig
ht
ed
 b
y 
on
e 
E
R
S
 p
ro
vi
d
er
.
P
at
ie
nt
s 
m
ee
t 
w
ith
 a
 h
ea
lth
 a
nd
 fi
tn
es
s 
ad
vi
so
r 
to
 d
is
cu
ss
 t
he
ir 
p
re
fe
re
nc
es
 
fo
r 
p
hy
si
ca
l a
ct
iv
ity
 a
nd
 a
n 
in
d
iv
id
ua
lly
 
ta
ilo
re
d
 1
2-
w
ee
k 
ex
er
ci
se
 p
ro
gr
am
m
e 
is
 d
es
ig
ne
d
 fo
r 
th
em
.
A
ct
iv
iti
es
 in
cl
ud
e 
th
e 
us
e 
of
 g
ym
s,
 
sw
im
m
in
g,
 fi
tn
es
s 
cl
as
se
s,
 b
ad
m
in
to
n 
an
d
 t
ab
le
 t
en
ni
s.
 T
he
 g
ym
s 
ar
e 
lo
ca
l 
au
th
or
ity
 o
r 
p
riv
at
el
y 
ow
ne
d
. P
riv
at
el
y 
ow
ne
d
 g
ym
s 
ar
e 
ob
lig
ed
 t
o 
of
fe
r 
th
ei
r 
fa
ci
lit
ie
s 
to
 B
e 
A
ct
iv
e 
P
lu
s 
p
ar
tic
ip
an
ts
. 
P
at
ie
nt
s 
ar
e 
al
so
 t
ol
d
 a
b
ou
t 
ac
tiv
iti
es
 
su
ch
 a
s 
th
e 
us
e 
of
 p
ar
ks
 a
nd
 o
p
en
 
sp
ac
es
 in
 B
irm
in
gh
am
 a
nd
 w
al
ki
ng
 t
o 
w
or
k,
 e
tc
.
P
ar
tic
ip
an
ts
 a
re
 a
ls
o 
co
nt
ac
te
d
 a
ft
er
 
3 
an
d
 6
 m
on
th
s 
an
d
 a
 r
ep
or
t 
is
 s
en
t 
to
 
th
ei
r 
G
P
 a
t 
th
ei
r 
12
-w
ee
k 
ex
it 
in
te
rv
ie
w
.
P
at
ie
nt
s 
m
ee
t 
w
ith
 a
n 
E
R
S
 a
d
vi
so
r 
fo
r 
b
eh
av
io
ur
al
 
ch
an
ge
 s
up
p
or
t 
an
d
 t
o 
d
es
ig
n 
a 
su
ita
b
le
 p
hy
si
ca
l 
ac
tiv
ity
 p
la
n.
P
at
ie
nt
s 
ar
e 
gi
ve
n 
in
fo
rm
at
io
n 
on
 a
 v
ar
ie
ty
 o
f p
hy
si
ca
l 
ac
tiv
ity
 o
p
tio
ns
 in
cl
ud
in
g 
th
os
e 
of
fe
re
d
 b
y 
le
is
ur
e 
ce
nt
re
s 
(e
g,
 fi
tn
es
s 
cl
as
se
s,
 s
w
im
m
in
g,
 g
ym
, e
tc
) a
s 
w
el
l a
s 
he
al
th
 w
al
ks
, h
om
e 
ex
er
ci
se
, a
ct
iv
e 
tr
av
el
, 
ap
p
s,
 e
tc
 a
nd
 a
re
 a
b
le
 t
o 
of
fe
r 
sp
ec
ia
lis
t 
gu
id
an
ce
 o
n 
ac
tiv
iti
es
 s
ui
ta
b
le
 fo
r 
th
os
e 
w
ith
 m
ed
ic
al
 c
on
d
iti
on
s 
an
d
/o
r 
d
is
ab
ili
tie
s.
P
at
ie
nt
s 
as
se
ss
ed
 a
s 
hi
gh
 r
is
k 
at
 r
ef
er
ra
l a
re
 s
cr
ee
ne
d
 
b
y 
a 
ca
rd
io
lo
gi
st
 p
rio
r 
to
 b
ei
ng
 a
cc
ep
te
d
 t
o 
th
e 
sc
he
m
e.
Th
er
e 
ar
e 
fix
ed
 c
on
ta
ct
 p
oi
nt
s 
of
 1
, 3
, 6
 a
nd
 
12
 m
on
th
s,
 b
ut
 p
at
ie
nt
s 
ca
n 
ch
oo
se
 h
ow
 o
ft
en
 t
he
y 
w
is
h 
su
p
p
or
t 
(te
le
p
ho
ne
, e
m
ai
l o
r 
fa
ce
-t
o-
fa
ce
) f
ro
m
 
th
e 
ad
vi
so
r 
in
 a
d
d
iti
on
 t
o 
th
es
e 
ov
er
 a
 1
2-
m
on
th
 
p
er
io
d
.
C
on
tin
ue
d
 o
n
 5 D
ecem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022382 on 21 September 2018. Downloaded from 
11Ingram W, et al. BMJ Open 2018;8:e022382. doi:10.1136/bmjopen-2018-022382
Open access
S
o
ut
h 
W
es
t 
E
ng
la
nd
 (p
re
d
o
m
in
an
tl
y 
P
ly
m
o
ut
h)
W
es
t 
M
id
la
nd
s 
(B
ir
m
in
g
ha
m
)
G
re
at
er
 G
la
sg
o
w
 a
nd
 C
ly
d
e 
(G
G
C
) H
ea
lt
h 
B
o
ar
d
 
A
re
a
C
os
t 
fo
r 
p
at
ie
nt
s 
in
 
E
R
S
 (i
f a
p
p
lic
ab
le
)
C
os
ts
 v
ar
y 
re
la
te
d
 t
o 
ag
e/
co
nc
es
si
on
s.
3 
m
on
th
s 
E
R
S
 c
os
ts
 b
et
w
ee
n 
£1
4.
90
 a
nd
 £
70
 
in
cl
us
iv
e 
of
 a
ll 
ac
tiv
iti
es
. P
ay
 a
s 
yo
u 
go
: £
2.
10
–
£3
.5
0 
p
er
 s
es
si
on
.
P
at
ie
nt
s 
ar
e 
no
t 
ch
ar
ge
d
 fo
r 
th
ei
r 
as
se
ss
m
en
t 
an
d
 s
up
p
or
t 
b
y 
th
e 
he
al
th
 
an
d
 fi
tn
es
s 
ad
vi
so
r. 
Th
e 
co
st
s 
of
 
th
e 
p
ro
gr
am
m
e 
d
ep
en
d
 o
n 
ch
os
en
 
ac
tiv
iti
es
 a
nd
 le
is
ur
e 
ce
nt
re
 a
tt
en
d
ed
.
P
at
ie
nt
s 
in
 r
ec
ei
p
t 
of
 s
ta
te
 b
en
efi
ts
 o
r 
ta
x 
cr
ed
its
 a
re
 e
lig
ib
le
 fo
r 
a 
P
as
sp
or
t 
to
 L
ei
su
re
 w
hi
ch
 e
nt
itl
es
 t
he
m
 t
o 
a 
30
%
 d
is
co
un
t 
on
 m
os
t 
ac
tiv
iti
es
 
of
fe
re
d
 a
t 
B
irm
in
gh
am
 C
ity
 C
ou
nc
il 
ru
n 
le
is
ur
e 
ce
nt
re
s,
 w
el
l-
b
ei
ng
 c
en
tr
es
 a
nd
 
sw
im
m
in
g 
p
oo
ls
. T
he
y 
ca
n 
at
te
nd
 fr
ee
 
B
e 
A
ct
iv
e 
se
ss
io
ns
 w
hi
ch
 t
ak
e 
p
la
ce
 a
t 
re
st
ric
te
d
 t
im
es
 in
 le
is
ur
e 
ce
nt
re
s.
Li
ve
 A
ct
iv
e 
b
eh
av
io
ur
al
 s
up
p
or
t 
is
 fr
ee
 t
o 
th
e 
p
at
ie
nt
 
fo
r 
12
 m
on
th
s.
If 
p
at
ie
nt
s 
w
is
h 
to
 u
se
 le
is
ur
e 
fa
ci
lit
ie
s,
 t
he
y 
ar
e 
en
tit
le
d
 t
o 
ac
ce
ss
 t
hi
s 
at
 a
 c
on
ce
ss
io
na
ry
 r
at
e 
(u
su
al
ly
 
ar
ou
nd
 3
0%
 r
ed
uc
tio
n)
.
N
um
b
er
 o
f p
eo
p
le
 
re
fe
rr
ed
 t
o 
lo
ca
l E
R
S
 
fr
om
 1
 A
ug
us
t 
20
15
 
to
 3
1 
M
ar
ch
 2
01
7 
(ie
, 
d
ur
in
g 
th
e 
re
cr
ui
tm
en
t 
p
er
io
d
 o
f t
he
 s
tu
d
y)
30
0
34
70
65
00
M
os
t 
co
m
m
on
 
p
rim
ar
y 
re
as
on
 fo
r 
re
fe
rr
al
s
(1
 A
ug
us
t 
20
15
 t
o 
31
 
M
ar
ch
 2
01
7)
*
D
ep
re
ss
io
n/
an
xi
et
y/
st
re
ss
: 2
4%
B
M
I>
30
: 2
8%
B
M
I≥
30
: 5
8%
*T
he
 d
at
a 
on
 p
rim
ar
y 
re
as
on
 fo
r 
re
fe
rr
al
 a
re
 s
ub
je
ct
iv
e 
as
 m
an
y 
p
at
ie
nt
s 
ha
ve
 m
ul
tip
le
 c
on
d
iti
on
s 
an
d
 a
 p
ra
ct
iti
on
er
 m
ay
 fa
vo
ur
 r
ec
or
d
in
g 
on
e 
co
nd
iti
on
 (e
g,
 o
b
es
ity
) r
at
he
r 
th
an
 a
no
th
er
 (e
g,
 
lo
w
 m
oo
d
). 
W
ith
in
 t
he
 r
es
p
ec
tiv
e 
sc
he
m
es
, t
he
 q
ua
lit
y 
of
 r
ec
or
d
in
g 
th
e 
re
fe
rr
al
 r
ea
so
n 
al
so
 a
p
p
ea
rs
 t
o 
b
e 
va
ria
b
le
.
B
M
I, 
b
od
y 
m
as
s 
in
d
ex
; E
R
S
, e
xe
rc
is
e 
re
fe
rr
al
 s
ch
em
e;
 G
P,
 g
en
er
al
 p
ra
ct
iti
on
er
. 
Ta
b
le
 3
 
C
on
tin
ue
d
 
 o
n
 5 D
ecem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022382 on 21 September 2018. Downloaded from 
12 Ingram W, et al. BMJ Open 2018;8:e022382. doi:10.1136/bmjopen-2018-022382
Open access 
 ► Adherence to physical activity, using a composite measure 
to describe the proportion in each arm of the trial that 
achieved at least 150 min of MVPA in bouts of at least 
10 min at 4 months and were still doing so at 12 months.
Self-reported survey process measures
 ► Single and multiple items, using Likert scales, to 
assess self-efficacy/confidence to be physically active, 
importance of being physically active, relatedness 
(perceived frequency and availability of support), 
perceived autonomy/control over physically active 
choices, involvement in self-monitoring and planning 
to do physical activity.
 ► In the intervention group, measures of engagement 
with e-coachER including whether or not the partici-
pant visits the website at least once, and whether they 
reach a stage of the online support to indicate they 
have set and reviewed at least one physical activity 
goal. Experience from engagement with other Life-
Guide online interventions suggests there may not be 
an optimum dose of engagement.
Economic evaluation
 ► Cost-effectiveness. Incremental cost of the interven-
tion to the NHS and incremental cost per change in 
minutes of MVPA (in ≥10 min bouts) and per QALY.
 ► An economic evaluation of e-coachER will be under-
taken using NHS, personal social services, and patient 
perspective. The analysis will be twofold—short-term 
(within-trial) cost-effectiveness analysis (from base-
line to 12 months postrandomisation) and long-term 
cost-effectiveness analysis (beyond-trial modelling 
of long-term expectations for cost-effectiveness), for 
e-coachER against ERS. The main outcome of the 
economic analysis will be an incremental cost per 
QALY (based on EQ-5D-5L). The short-term cost-ef-
fectiveness analysis will use resource use data for 
development of training of and input from a local 
LifeGuide facilitator, and central LifeGuide techni-
cian; provision and running of the exercise sessions at 
leisure centres and health and personal social service 
use. Data will be collected using the e-coachER moni-
toring system, key informant interviews (including 
trial manager), review of trial management records 
and participants’ questionnaires at baseline, 4 and 12 
months. Unit costs will be taken from the NHS refer-
ence costs (eg, DH 2015/2016),38 standard unit costs39 
and published literature. The long-term cost-effective-
ness of e-coachER will be based on an existing poli-
cy-relevant decision analytical model.40 41 The analysis 
will account for the impact of physical activity on life-
time risk of developing coronary heart disease, stroke 
and type 2 diabetes.
Process evaluation
The barriers to, and facilitators for, recruitment will be 
explored with participants in the early stages of the trial 
through qualitative interviews with local researchers 
at each site, and also via local researcher field notes of 
conversations with participants at various stages of the 
trial. Along with relevant supporting literature, this infor-
mation will be used to optimise recruitment during the 
remainder of the trial.
Following guidelines for evaluating complex interven-
tions,42 a nested mixed methods process evaluation will 
be undertaken, focussing on identifying factors relating to 
recruitment, engagement, acceptability, mechanisms and 
fidelity.
The assessment of barriers and facilitators in recruit-
ment will involve the following:
1. Interviews with researchers about patient-reported rea-
sons for joining the study or not;
2. Interviews with researchers about barriers to recruit-
ment in the primary care setting, and among exercise 
referral practitioners.
The logic model shown in figure 2 will guide the process 
evaluation of the intervention. The logic model shows the 
types of data that will be collected, as well as the causal 
pathways proposed to contribute to behaviour change 
and intervention outcomes.
The assessment of intervention engagement and 
acceptability will involve the following:
1. Semi-structured interviews with up to 10% of the in-
tervention group participants. A purposeful sampling 
framework will be used to ensure participants with 
a range of characteristics (gender, age, underlying 
health condition and trial centre) are invited to take 
part. Interviews will be conducted at different stages 
of participation in the trial, with each individual be-
ing invited to participate in telephone interviews 
and if appropriate follow-up interviews (up to a max-
imum of three telephone interviews over the course 
of the intervention period (approximately 4 months). 
Interviews will be recorded and transcribed and per-
sonal data or ways of identifying participants removed. 
Transcriptions will be imported into NVivo for data 
management purposes. The interview transcripts will 
be coded and thematic analysis performed to iden-
tify key findings. Analysis will initially focus on ‘top 
level’ themes, reflected in the intervention logic mod-
el. Analysis will follow the principles of Framework 
Analysis.43 Further in-depth analysis will also be un-
dertaken in order to ensure emergent data, for ex-
ample, from longitudinal cases, or condition-specific 
themes, are explored fully. The focus of the interview 
questions will be linked to the phase of the interven-
tion, and seek to identify the perceived value of the 
‘Welcome Pack’ and contents in helping to access 
e-coachER, the overall web-based support and each 
of the Steps to Health, in terms of functionality and 
utility to support behaviour change. Participants will 
be asked to identify if and how they thought e-coach-
ER provided support for their ERS, and maintaining 
physical activity in addition to and beyond the ERS 
support. Ideas for additions or revisions to e-coach-
ER will be requested. Questions will also focus on the 
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participants’ perceived development of self-regulatory 
skills (eg, self-monitoring, goal setting) and the extent 
to which the intervention enhanced a sense of compe-
tence, autonomy and relatedness, thereby linking back 
to the aims and guiding principles of the e-coachER 
intervention.
2. The researchers will be asked to maintain field notes 
on any interactions with participants concerning en-
gagement with the intervention, such as any difficul-
ties faced with accessing the intervention website. 
Semi-structured interviews will be conducted by the 
qualitative researcher with the researchers at each re-
cruitment site to identify participant barriers and facil-
itators to using e-coachER.
3. Engagement with the web-based e-coachER support 
system will be quantified. Metrics such as whether 
the participant registered, how far they progressed in 
the seven Steps to Health, visits to and time spent on 
different web pages and within each of the respective 
Steps, number of times step counts or amount of phys-
ical activity (eg, MVPA) were entered into e-coachER 
(ie, self-monitoring) and number of times goals were 
achieved and reviewed.
4. Changes in the process measures (see above) (eg, 
self-efficacy/confidence to be and importance of be-
ing physically active) from baseline to 4 and 12 months 
follow-up will be assessed and compared between in-
tervention arms.
5. Mediation analysis to determine the extent to which 
changes in the process measures mediate the effect 
of the intervention on changes in physical activity at 4 
and 12 months.
data handling
Data will be collected and stored in accordance with the 
Data Protection Act 1998/General Data Protection Regu-
lation 2018.
Subject numbering
Following receipt of expression of interest, each patient 
will be allocated a unique number and will then be identi-
fied in all study-related documentation by their identifi-
cation number and initials. A record of names, addresses, 
telephone numbers and email addresses linked to partic-
ipants’ identification numbers will be stored securely 
on the study database for administrative purposes 
only.
Data collection
Data will be recorded on study-specific paper-based case 
report forms (CRFs) by the local researcher, and partici-
pants will complete a paper-based questionnaire booklet 
comprising validated and non-validated self-report 
outcome measures (listed in table 1).
Accelerometers will be configured for use prior to issue 
to participants by the local researcher at baseline and the 
CTU thereafter, using GENEActiv software. A recording 
window of 10 days, recording at 75 Hz, will be preset, thus 
accounting for transits in the post while optimising the 
battery life of the device.
Accelerometers received by the CTU following 1 weeks’ 
wear by the participant will be physically cleaned with 
liquid detergent (according to manufacturer’s instruc-
tions) before data are downloaded via GENEActiv soft-
ware and linked to participant identification number. 
Accelerometers will then be issued to other participants 
in the trial as required.
Data on participants’ uptake of the ERS will be collected 
via a single use token-based authenticated email sent to 
participants at 4 weeks post-baseline. This will be a short 
survey requesting information on whether the participant 
has attended the initial consultation with the ERS advisor, 
and predefined reasons for non-attendance status, for 
example, appointment has been booked but not yet 
attended.
All persons authorised to collect and record study data 
at each site will be listed on the study site delegation logs, 
signed by the Principal Investigator.
Data entry
Original CRFs and questionnaire booklets will be posted 
to the CTU, with copies of the CRF retained at the study 
site. All data will be double-entered by CTU staff on to a 
password-protected SQL Server database and encrypted 
using Secure Sockets Layer. Double-entered data will be 
compared for discrepancies using a stored procedure and 
discrepant data will be verified using the original CRF. 
Incomplete, incoherent, unreadable or other problem 
data in the CRF pages will be queried by the CTU with 
study site staff during data entry to ensure a complete 
and valid dataset. Self-reported data in the questionnaire 
booklet will not be queried with participants.
The CTU may complete further validation of data 
items, perform logical data checks and raise further data 
queries after data collection has been completed. The 
final export of anonymous data will be transferred to 
statisticians for analysis after all data cleaning duties have 
been performed by the CTU.
data analysis plan
All analyses will be carried out using a detailed a priori 
statistical analysis plan. Analyses will be reported in full 
and in accordance with the  Consolidated Standards of 
Reporting Trials (CONSORT) guidelines.44 Recruitment, 
uptake of the ERS, engagement with the intervention, 
outcome completion rates and study withdrawal will be 
reported (with 95% CIs). Baseline characteristics in the 
two trial arms will be reported.
The primary analysis will compare complete case outcomes 
between intervention and control arms groups according to 
the principle of intention to treat (ie, according to original 
randomised allocation) at 12 months adjusting for baseline 
outcome values and stratification and minimisation variables 
(recruitment site and disease indication).
Secondary analyses will be undertaken to compare 
groups at follow-up across all follow-up points (ie, 4 and 
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12 months) using a mixed effects repeated measures 
approach. In addition, we will seek to undertake 
secondary per-protocol analyses using a complier average 
causal effect approach to examine the impact of different 
levels of the adherence to the intervention.
Accelerometry data will be analysed with bespoke soft-
ware to classify data into levels of physical activity intensity 
using accepted cut-points. Standard operating proce-
dures will be applied to make a decision about dealing 
with missing data.
The primary analysis model will be extended to fit inter-
action terms to explore possible subgroup differences 
in intervention effect in stratification and minimisation 
variables and the predefined baseline characteristics. As 
not formally powered, these subgroup analyses will be 
regarded as exploratory and hypothesis-generating.
Sensitivity analysis, using multiple imputation and 
assuming unobserved measurements are missing at 
random will be conducted for both primary and secondary 
analyses to assess the likely impact of missing data on the 
primary and secondary outcomes at 12 months. Contem-
porary mediational analysis methods45 will be used to 
explore the impact of process outcomes identified in the 
planned intervention components, including engage-
ment, use of behaviour change techniques and motiva-
tion and processes of change (eg, self-efficacy, autonomy, 
relatedness).
No interim analysis of primary or secondary outcomes 
is planned. No adjustment of p-values will be made to 
account for multiple testing, although the implications of 
multiple testing will be considered when evaluating the 
results of the analyses. Analysis of the primary outcome 
will be performed prior to all other analyses. All analyses 
will be undertaken using STATA V.14.2.
Checks will be undertaken to assess the robustness of 
models, including assessment of model residual normality 
and heteroscedasticity.
Patient and public involvement
The research question was informed by patient and 
public involvement (PPI) over many years. Individual and 
group interviews were conducted with patients to identify 
the barriers and facilitators associated with ERS, and what 
additional support could help maintain physical activity 
for a variety of chronic conditions. Our extensive engage-
ment with ERS practitioners allowed us to understand the 
individual variability and collective patient experience 
of ERS. This included one of the authors developing, 
delivering and adapting a training course for ERS practi-
tioners based on their feedback.
The LifeGuide team worked extensively with PPI 
representatives to develop the appropriate support, 
concluding that ERS patients would appreciate additional 
support from an ERS to help them to further develop the 
independent motivation to maintain physical activity, 
involving a broad range of active options. Also, patients 
widely indicated that the LifeGuide web-based system 
can provide appropriate support for making health 
behaviour changes. Typically ERS can increase health 
inequalities by limiting access to those who have limited 
disposable income or have restricting physical and mental 
health conditions. The e-coachER system was designed to 
support those with such restrictions.
Patients were involved in the design of the study. A PPI 
group was involved in the initial development and refine-
ment of the e-coachER web-based behavioural support. 
Patients with experience of being referred for an exer-
cise programme, took part in focus groups and provided 
direct feedback on iterations of the e-coachER interven-
tion during its development.
We engaged with over 20 ERS patients who volunteered 
to pilot the e-coachER Welcome Pack and provide feed-
back on the e-coachER website. A PPI representative was 
available to provide opinions on the study protocol and 
patient-facing documentation (eg, Participant Informa-
tion Sheet) during the set-up of the study.
Patients are involved in the oversight of study prog-
ress and conduct via representation at periodic Project 
Management Group meetings and Trial Steering 
Committee meetings.
Results will be disseminated to study participants. 
At the end of the trial, a plain English summary of the 
study results will be made available to participants via a 
designated webpage on the Peninsula Clinical Trials Unit 
website, and emailed or posted to participants on request.
trial monitoring and oversight
A Project Management Group including the Chief Inves-
tigator, Principal Investigators, co-applicants, CTU Trial 
Manager, ERS advisor and PPI representative will meet 
quarterly to provide multidisciplinary input and oversight 
for the study.
A Trial Steering Committee (TSC) including an inde-
pendent chair, independent clinicians and/or academics 
with relevant expertise, independent statistician/meth-
odologist with relevant expertise and a representative 
contributing a patient/public perspective will oversee 
the conduct and scientific integrity of the trial. The TSC 
will review study progress and protocol adherence. Each 
committee will function in accordance with agreed terms 
of reference set out in a charter.
An independent Data Monitoring Committee (DMC) 
will monitor the safety and ethics of the trial by over-
seeing recruitment, primary outcome data completeness 
and serious adverse event data.
The committees will meet once before the start of the 
trial and approximately annually thereafter.
EthICs And dIssEMInAtIon
safety considerations
The recording and reporting of non-serious adverse 
events in this study will not be required. Serious adverse 
events (SAE) will be captured via survey-specific items on 
hospital admissions in the questionnaire booklet at 4 and 
12 months, that is, reason and duration of the inpatient 
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stay, and self-reported relatedness of the SAE to partici-
pation in the trial; self-report independent of the ques-
tionnaire booklet; notification to the local researcher by 
the participant’s relative/advocate or notification by the 
participant’s GP.
Reports of SAEs will be provided to the CTU. The CTU 
will liaise with the local researcher who will be responsible 
for ascertaining further details about the SAE as appro-
priate. The Chief Investigator will report any SAE that is 
related (definitely, possibly or probably related) to the 
research procedures to the Research Ethics Committee 
within 15 days of becoming aware of the event. The CTU 
will prepare quarterly summaries of SAEs for review by 
the independent DMC and Sponsor.
dissemination plan
The findings of the study will be made publicly available 
through publication in relevant peer-reviewed journals 
and the NIHR Journals Library website; and presenta-
tion to the scientific community, patient support groups, 
the ERS services and NHS strategy forums at local and 
national level. The study is reported in accordance with 
CONSORT guidelines for publishing randomised trials 
and TIDieR guidelines for intervention reporting.
A plain English summary of the main study results will be 
made available for participants and other lay audiences.
Changes to the protocol after the start of the trial
Primary outcome measure and sample size
The original protocol featured an internal pilot. During 
the internal pilot phase, 180 patients were to be recruited 
over 3 months to provide sufficient information to justify 
progression to a main trial. Progression from the internal 
pilot to the main trial was dependent on recruitment rate 
and engagement with the intervention according to the 
scenarios in table 4. In the main trial, an additional 1220 
participants were to be recruited, giving a total of 1400 
participants (recruited over 16 months).
The recruitment rate during the internal pilot phase 
was lower than expected, due to limitations on the time 
primary care practitioners had available to approach 
potential participants; delayed start at one of the research 
sites; poor uptake when patients were approached via a 
postal mailshot; high ineligibility rate among patients who 
were identified via a primary care database. In response 
to poor recruitment, the following strategies to increase 
recruitment were introduced:
 ► The inclusion criterion for BMI was aligned with the 
ERS entry (upper BMI limit for the trial was originally 
35 and was raised to 40), and prediabetes was included 
as an inclusion criterion.
 ► Recruitment via the ERS service, which was already 
taking place at the site in Greater Glasgow, was 
adopted in the West Midlands and the South West in 
addition to recruitment via primary care.
 ► Incentive payments to participants (for returning an 
accelerometer) were increased from £10 to £20 per 
accelerometer.
Having implemented these measures, the conditions 
for progression in terms of recruitment rate and engage-
ment with the intervention were not met by the end of the 
internal pilot phase, despite a 4-month extension period. 
A ‘recovery plan’ was developed in collaboration with 
the funders, based on amending the choice of primary 
outcome, and submitted in May 2016.
The original primary outcome was achievement of at 
least 150 min of MVPA measured objectively by acceler-
ometer over 1 week at 12 months. This outcome was based 
on the findings of a systematic review of ERS12 46 demon-
strating that trials had primarily reported their outcomes 
according to percentage of participants reaching the 
National Institute for Health and Care Excellence guide-
lines for physical activity level, that is, 150 min of MVPA 
per week. We estimated that recruiting 700 participants 
per group would allow us to detect a difference at 12 
months follow-up of at least 10% (intervention group: 
53% vs control group: 43%), assuming an attrition rate of 
20% and small effect of clustering (intracluster correla-
tion coefficient ICC: 0.006) at 90% power and 5% alpha. 
Thus, the original sample size was 1400 participants, to be 
recruited over 16 months.
From the outset, the TSC and DMC had recommended 
that this dichotomous primary outcome measure be 
replaced with a continuous variable; total weekly minutes 
of MVPA. This was because:
a. A continuous primary outcome measure would be 
more relevant in this study population, in terms of 
detecting a small but clinically significant increase in 
minutes of MVPA.
Table 4 Internal pilot to main trial progression rules
Criteria Scenario 3 Scenario 2 Scenario 1
% of internal pilot sample size target (180 patients) 
recruited
<65% 65%–79% ≥80%
Intervention engagement
(% participants who access e-coachER at least 
once)
<65% 65%–79% ≥80%
Proposed action No progression Discuss with Trial Steering 
Committee and funder about 
progression and resources 
needed to achieve target.
Proceed to full trial.
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b. Based on sample size calculations, this would offer 
greater statistical power than to the categorical as-
sessment of whether participants reach a threshold of 
150 min of MVPA. This would therefore afford a reduc-
tion in sample size.
The TSC and funders agreed these changes (in August 
2016) and the original sample size was reduced in accord-
ance with this new primary outcome measure and revised 
sample size calculation, from 1400 to 413 participants 
(to be recruited over 21 months). A similar reduction in 
sample size has been incorporated into the qualitative 
component of the process evaluation work.
Current study status
The e-coachER trial began recruiting patients in August 
2015 and closed to recruitment in March 2017. Data 
collection is expected to be completed in March 2018 
and results are expected to be published in September 
2018.
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